Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review
Importance Observational (nonexperimental) studies that aim to emulate a randomized trial
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
[HTML][HTML] Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta …
Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …
Using trial and observational data to assess effectiveness: Trial emulation, transportability, benchmarking, and joint analysis
IJ Dahabreh, A Matthews… - Epidemiologic …, 2023 - academic.oup.com
Comparisons between randomized trial analyses and observational analyses that attempt to
address similar research questions have generated many controversies in epidemiology …
address similar research questions have generated many controversies in epidemiology …
A gender lens is needed in hepatitis C elimination research
Abstract The World Health Organisation has established a goal of eliminating the hepatitis C
virus (HCV) as a public health threat by 2030. Considerable effort is being directed towards …
virus (HCV) as a public health threat by 2030. Considerable effort is being directed towards …
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre‐and post‐unrestricted availability of direct acting antiviral therapies
Abstract Aims The 2016 Global Health Sector Strategy (GHSS) on viral hepatitis aims to
reduce new hepatitis C virus (HCV) infections by 80% by 2030, including a 30% reduction …
reduce new hepatitis C virus (HCV) infections by 80% by 2030, including a 30% reduction …
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different …
Abstract Background and Aims Although the Netherlands, Canada and Australia were early
adopters of harm reduction for people who inject drugs (PWID), their respective HIV and …
adopters of harm reduction for people who inject drugs (PWID), their respective HIV and …
High-risk polysubstance use among LGBTQ+ people who use drugs in the United States: An application of syndemic theory
CJ Cascalheira, J Nelson, RE Flinn, Y Zhao… - International Journal of …, 2023 - Elsevier
Background Compared to heterosexual and cisgender people, lesbian, gay, bisexual,
transgender, queer, and other sexual and gender minority (LGBTQ+) people are more likely …
transgender, queer, and other sexual and gender minority (LGBTQ+) people are more likely …
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review
Social determinants of health are important in designing effective interventions for hepatitis
B virus (HBV) infection. This systematic review characterises equity-oriented, social …
B virus (HBV) infection. This systematic review characterises equity-oriented, social …
[HTML][HTML] HIV and liver disease: a comprehensive update
KE Sherman, DL Thomas - Topics in Antiviral Medicine, 2022 - ncbi.nlm.nih.gov
Despite substantial advances in the field, liver disease morbidity and mortality remain
serious issues among people with HIV. The causes of liver disease are often multifactorial …
serious issues among people with HIV. The causes of liver disease are often multifactorial …
[HTML][HTML] HCV elimination in a Swiss opioid agonist therapy programme–a cohort study
A Bregenzer, C Krismer, S Wendel, P Roser… - Swiss Medical …, 2022 - smw.ch
BACKGROUND: In opioid agonist therapy (OAT) programmes, chronic hepatitis C is highly
prevalent and directly observed therapy guarantees optimal adherence. Since 2017, all …
prevalent and directly observed therapy guarantees optimal adherence. Since 2017, all …